{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:46:06Z","timestamp":1791297966993,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2007,5,8]],"date-time":"2007-05-08T00:00:00Z","timestamp":1178582400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2007,6,5]]},"DOI":"10.1007\/s00125-007-0692-2","type":"journal-article","created":{"date-parts":[[2007,5,7]],"date-time":"2007-05-07T13:23:31Z","timestamp":1178544211000},"page":"1532-1540","source":"Crossref","is-referenced-by-count":93,"title":["Early administration of the glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3)GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob\/ob mice"],"prefix":"10.1007","volume":"50","author":[{"given":"N.","family":"Irwin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"McClean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. P. M.","family":"O\u2019Harte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. A.","family":"Gault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Harriott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R.","family":"Flatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,8]]},"reference":[{"key":"692_CR1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1210\/endo-99-3-780","volume":"99","author":"RA Pederson","year":"1976","unstructured":"Pederson RA, Brown JC (1976) The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas. Endocrinology 99:780\u2013785","journal-title":"Endocrinology"},{"key":"692_CR2","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1055\/s-2001-18589","volume":"109","author":"W Creutzfeldt","year":"2001","unstructured":"Creutzfeldt W (2001) The entero-insular axis in type 2 diabetes-incretins as therapeutic agents. Exp Clin Endocrinol Diabetes 109:S288\u2013S303","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"692_CR3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-2004-826158","volume":"36","author":"JJ Holst","year":"2004","unstructured":"Holst JJ (2004) On the physiology of GIP and GLP-1. Horm Metab Res 36:747\u2013754","journal-title":"Horm Metab Res"},{"key":"692_CR4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1677\/joe.0.1740233","volume":"174","author":"A Trumper","year":"2002","unstructured":"Trumper A, Trumper K, Horsch D (2002) Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J Endocrinol 174:233\u2013246","journal-title":"J Endocrinol"},{"key":"692_CR5","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1210\/en.2002-0068","volume":"144","author":"JA Ehses","year":"2003","unstructured":"Ehses JA, Casilla VR, Doty T et al (2003) Glucose-dependent insulinotropic polypeptide promotes beta-(INS-1) cell survival via cyclic adenosine monophosphate-mediated caspase-3 inhibition and regulation of p38 mitogen-activated protein kinase. Endocrinology 144:4433\u20134445","journal-title":"Endocrinology"},{"key":"692_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev.med.57.110104.115624","volume":"57","author":"LL Baggio","year":"2006","unstructured":"Baggio LL, Drucker DJ (2006) Therapeutic approaches to preserve islet mass in type 2 diabetes. Annu Rev Med 57:265\u2013281","journal-title":"Annu Rev Med"},{"key":"692_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/gut.50.3.341","volume":"50","author":"J Schirra","year":"2002","unstructured":"Schirra J, Wank U, Arnold R, Goke B, Katschinski M (2002) Effects of glucagon-like peptide-1(7\u201336)amide on motility and sensation of the proximal stomach in humans. Gut 50:341\u2013348","journal-title":"Gut"},{"key":"692_CR8","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.2174\/1381612043382774","volume":"10","author":"BD Green","year":"2004","unstructured":"Green BD, Gault VA, O\u2019Harte FP, Flatt PR (2004) Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents. Curr Pharm Des 10:3651\u20133662","journal-title":"Curr Pharm Des"},{"key":"692_CR9","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2337\/diacare.26.10.2929","volume":"26","author":"DJ Drucker","year":"2003","unstructured":"Drucker DJ (2003) Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26:2929\u20132940","journal-title":"Diabetes Care"},{"key":"692_CR10","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1055\/s-2004-826160","volume":"36","author":"CF Deacon","year":"2004","unstructured":"Deacon CF (2004) Circulation and degradation of GIP and GLP-1. Horm Metab Res 36:761\u2013765","journal-title":"Horm Metab Res"},{"key":"692_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.npep.2003.09.002","volume":"37","author":"VA Gault","year":"2003","unstructured":"Gault VA, O\u2019Harte FP, Flatt PR (2003) Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential? Neuropeptides 37:253\u2013263","journal-title":"Neuropeptides"},{"key":"692_CR12","doi-asserted-by":"crossref","first-page":"E199","DOI":"10.1152\/ajpendo.00545.2003","volume":"287","author":"JJ Holst","year":"2004","unstructured":"Holst JJ, Gromada J (2004) Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Am J Physiol Endocrinol Metab 287:E199\u2013E206","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"692_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","volume":"91","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7\u201336 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301\u2013307","journal-title":"J Clin Invest"},{"key":"692_CR14","doi-asserted-by":"crossref","first-page":"S220","DOI":"10.2337\/diabetes.53.suppl_3.S220","volume":"53","author":"JJ Meier","year":"2004","unstructured":"Meier JJ, Gallwitz B, Kask B et al (2004) Stimulation of insulin secretion by intravenous bolus injection and continuous infusion of gastric inhibitory polypeptide in patients with type 2 diabetes and healthy control subjects. Diabetes 53:S220\u2013S224","journal-title":"Diabetes"},{"key":"692_CR15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0026-0495(03)00327-5","volume":"52","author":"JJ Meier","year":"2003","unstructured":"Meier JJ, Nauck MA, Siepmann N et al (2003) Similar insulin secretory response to a gastric inhibitory polypeptide bolus injection at euglycemia in first-degree relatives of patients with type 2 diabetes and control subjects. Metabolism 52:1579\u20131585","journal-title":"Metabolism"},{"key":"692_CR16","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00125-005-1863-7","volume":"48","author":"JJ Meier","year":"2005","unstructured":"Meier JJ, Gallwitz B, Askenas M et al (2005) Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. Diabetologia 48:1872\u20131881","journal-title":"Diabetologia"},{"key":"692_CR17","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s001250051051","volume":"41","author":"K Almind","year":"1998","unstructured":"Almind K, Ambye L, Urhammer SA et al (1998) Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells. Diabetologia 41:1194\u20131198","journal-title":"Diabetologia"},{"key":"692_CR18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/diabetes.52.2.380","volume":"52","author":"LL Kjems","year":"2003","unstructured":"Kjems LL, Holst JJ, Volund A, Madsbad S (2003) The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52:380\u2013386","journal-title":"Diabetes"},{"key":"692_CR19","first-page":"247","volume":"18","author":"D Porte Jr","year":"1995","unstructured":"Porte D Jr, Kahn SE (1995) The key role of islet dysfunction in type II diabetes mellitus. Clin Invest Med 18:247\u2013254","journal-title":"Clin Invest Med"},{"key":"692_CR20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0024-3205(99)00314-8","volume":"66","author":"RG Yip","year":"2000","unstructured":"Yip RG, Wolfe MM (2000) GIP biology and fat metabolism. Life Sci 66:91\u2013103","journal-title":"Life Sci"},{"key":"692_CR21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1139\/y69-020","volume":"47","author":"JC Brown","year":"1969","unstructured":"Brown JC, Pederson RA, Jorpes JE, Mutt V (1969) Preparation of a highly active enterogastrone. Can J Physiol Pharmacol 47:113\u2013114","journal-title":"Can J Physiol Pharmacol"},{"key":"692_CR22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0167-0115(80)90026-9","volume":"1","author":"DK Andersen","year":"1980","unstructured":"Andersen DK, Putnam WS, Hanks JB, Wise JE, Lebovitz HE, Jones RS (1980) Gastric inhibitory polypeptide (GIP) suppression of hepatic glucose production. Regul Pept 1:4\u20139","journal-title":"Regul Pept"},{"key":"692_CR23","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/diabetes.53.9.2359","volume":"53","author":"NN Rudovich","year":"2004","unstructured":"Rudovich NN, Rochlitz HJ, Pfeiffer AF (2004) Reduced hepatic insulin extraction in response to gastric inhibitory polypeptide compensates for reduced insulin secretion in normal-weight and normal glucose tolerant first-degree relatives of type 2 diabetic patients. Diabetes 53:2359\u20132365","journal-title":"Diabetes"},{"key":"692_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1677\/joe.0.1560237","volume":"156","author":"FPM O\u2019Harte","year":"1998","unstructured":"O\u2019Harte FPM, Gray AM, Flatt PR (1998) Gastric inhibitory polypeptide and effects of glycation on glucose transport and metabolism in isolated mouse abdominal muscle. J Endocrinol 156:237\u2013243","journal-title":"J Endocrinol"},{"key":"692_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1677\/joe.0.1300267","volume":"130","author":"J Oben","year":"1991","unstructured":"Oben J, Morgan L, Fletcher J, Marks V (1991) Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7\u201336) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130:267\u2013272","journal-title":"J Endocrinol"},{"key":"692_CR26","first-page":"183","volume":"125","author":"JM Knapper","year":"1995","unstructured":"Knapper JM, Puddicombe SM, Morgan LM, Fletcher JM (1995) Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon like peptide-1(7\u201336)amide on lipoprotein lipase activity in explants of rat tissue. J Nutr 125:183\u2013188","journal-title":"J Nutr"},{"key":"692_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2337\/diab.27.3.327","volume":"27","author":"SA Ross","year":"1978","unstructured":"Ross SA, Dupre J (1978) Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects. Diabetes 27:327\u2013333","journal-title":"Diabetes"},{"key":"692_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00429703","volume":"14","author":"W Creutzfeldt","year":"1978","unstructured":"Creutzfeldt W, Ebert R, Willms B, Frerichs H, Brown JC (1978) Gastric inhibitory polypeptide (GIP) and insulin in obesity: increased response to stimulation and defective feedback control of serum levels. Diabetologia 14:15\u201324","journal-title":"Diabetologia"},{"key":"692_CR29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2337\/diab.32.5.433","volume":"32","author":"PR Flatt","year":"1983","unstructured":"Flatt PR, Bailey CJ, Kwasowski P, Swanston-Flatt SK, Marks V (1983) Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice. Diabetes 32:433\u2013435","journal-title":"Diabetes"},{"key":"692_CR30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nm727","volume":"8","author":"K Miyawaki","year":"2002","unstructured":"Miyawaki K, Yamada Y, Ban N et al (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738\u2013742","journal-title":"Nat Med"},{"key":"692_CR31","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1006\/bbrc.2002.6364","volume":"290","author":"VA Gault","year":"2002","unstructured":"Gault VA, O\u2019Harte FPM, Harriott P, Flatt PR (2002) Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. Biochem Biophys Res Commun. 290:1420\u20131426","journal-title":"Biochem Biophys Res Commun"},{"key":"692_CR32","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.2337\/diabetes.54.8.2436","volume":"54","author":"VA Gault","year":"2005","unstructured":"Gault VA, Irwin N, Green BD et al (2005) Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3)GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity-related diabetes. Diabetes 54:2436\u20132446","journal-title":"Diabetes"},{"key":"692_CR33","first-page":"11","volume":"6","author":"CJ Bailey","year":"1982","unstructured":"Bailey CJ, Flatt PR, Atkins TW (1982) Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob\/ob mice. Int J Obes 6:11\u201321","journal-title":"Int J Obes"},{"key":"692_CR34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1515\/BC.2004.110","volume":"385","author":"N Irwin","year":"2004","unstructured":"Irwin N, Gault VA, Green BD et al (2004) Effects of short-term chemical ablation of the GIP receptor on insulin secretion, islet morphology and glucose homeostasis in mice. Biol Chem 385:845\u2013852","journal-title":"Biol Chem"},{"key":"692_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-291X(03)01361-5","volume":"308","author":"VA Gault","year":"2003","unstructured":"Gault VA, Flatt PR, O\u2019Harte FPM (2003) Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetes. Biochem Biophys Res Commun 308:207\u2013213","journal-title":"Biochem Biophys Res Commun"},{"key":"692_CR36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00125-002-1028-x","volume":"46","author":"VA Gault","year":"2003","unstructured":"Gault VA, O\u2019Harte FP, Harriott P, Mooney MH, Green BD, Flatt PR (2003) Effects of the novel (Pro3)GIP antagonist and exendin(9\u201339)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob\/ob) mice: evidence that GIP is the major physiological incretin. Diabetologia 46:222\u2013230","journal-title":"Diabetologia"},{"key":"692_CR37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/BF00252768","volume":"20","author":"PR Flatt","year":"1981","unstructured":"Flatt PR, Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob\/+) mice. Diabetologia 20:573\u2013577","journal-title":"Diabetologia"},{"key":"692_CR38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"692_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4684-7248-6_21","volume":"106","author":"JC Brown","year":"1978","unstructured":"Brown JC, Dryburgh JR, Frost JL, Otte SC, Pederson RA (1978) Physiology and pathophysiology of GIP. Adv Exp Med Biol 106:169\u2013171","journal-title":"Adv Exp Med Biol"},{"key":"692_CR40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.0.1010249","volume":"101","author":"PR Flatt","year":"1984","unstructured":"Flatt PR, Bailey CJ, Kwaskowski P, Page T, Marks V (1984) Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob\/ob) mice. J Endocrinol 101:249\u2013256","journal-title":"J Endocrinol"},{"key":"692_CR41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1530\/acta.0.1120224","volume":"112","author":"CJ Bailey","year":"1986","unstructured":"Bailey CJ, Flatt PR, Kwasowski P, Powell CJ, Marks V (1986) Immunoreactive gastric inhibitory polypeptide and K cell hyperplasia in obese hyperglycaemic (ob\/ob) mice fed high fat and high carbohydrate cafeteria diets. Acta Endocrinol (Copenh) 112:224\u2013229","journal-title":"Acta Endocrinol (Copenh)"},{"key":"692_CR42","first-page":"25.1","volume-title":"Textbook of diabetes, 3rd edn","author":"CJ Bailey","year":"2003","unstructured":"Bailey CJ, Flatt PR (2003) Animal syndromes resembling type 2 diabetes. In: Pickup JC, Williams G (eds) Textbook of diabetes, 3rd edn. Blackwell Science, Oxford, pp 25.1\u201325.30"},{"key":"692_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1172\/JCI25483","volume":"117","author":"T Hansotia","year":"2007","unstructured":"Hansotia T, Maida A, Flock G et al (2007) Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J Clin Invest 117:143\u2013152","journal-title":"J Clin Invest"},{"key":"692_CR44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/cs0930343","volume":"9","author":"R Gama","year":"1997","unstructured":"Gama R, Norris F, Morgan L, Hampton S, Wright J, Marks V (1997) Elevated post-prandial gastric inhibitory polypeptide concentrations in hypertriglyceridaemic subjects. Clin Sci (Lond) 9:343\u2013347","journal-title":"Clin Sci (Lond)"},{"key":"692_CR45","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.96.26.14843","volume":"96","author":"K Miyawaki","year":"1999","unstructured":"Miyawaki K, Yamada Y, Yano H et al (1999) Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Nat Acad Sci USA 96:14843\u201314847","journal-title":"Proc Nat Acad Sci USA"},{"key":"692_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000313480407000101","volume":"70","author":"RH Clements","year":"2004","unstructured":"Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HR (2004) Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type II diabetes mellitus. Am Surg 70:1\u20135","journal-title":"Am Surg"},{"key":"692_CR47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.sla.0000133117.12646.48","volume":"240","author":"F Rubino","year":"2004","unstructured":"Rubino F, Gagner M, Gentileschi P et al (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236\u2013242","journal-title":"Ann Surg"},{"key":"692_CR48","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/db06-0068","volume":"55","author":"C Guidone","year":"2006","unstructured":"Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025\u20132031","journal-title":"Diabetes"},{"key":"692_CR49","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00125-006-0337-x","volume":"49","author":"A Mari","year":"2006","unstructured":"Mari A, Manco M, Guidone C et al (2006) Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 49:2136\u20132143","journal-title":"Diabetologia"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-007-0692-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-007-0692-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-007-0692-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:46:23Z","timestamp":1683830783000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-007-0692-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,8]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,6,5]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1007\/s00125-007-0692-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,8]]}}}